Women’s imaging encompasses many radiology procedures related to women and the diseases that are most prevalent to women such as breast cancer or gynecological issues. Mammogram, breast ultrasound, breast MRI and breast biopsy are the most commonly used procedures.
“Incorporating patient perspectives into AI implementation strategies ensures that these technologies improve and not hinder patient care," one expert contends.
Gov. Sarah Huckabee Sanders signed Senate Bill 123 into law on April 14 following its passage by the state legislature, weeks after Virginia passed a similar bill.
The acquisition will give Los Angeles-based RadNet an installed base of more than 1,500 healthcare provider locations, facilitating 8 million mammograms across 50 countries.
Incidence rates among women 50 to 64 have now surpassed those of men, while cancer rates for females under 50 are 82% higher than their male counterparts, the ACS reports.
Those proposing breast imaging-related measures so far in 2025 have included Connecticut, Florida, Hawaii, Indiana, Missouri, New York, South Carolina, Utah and Virginia, ACR reports.
The National Mammography Quality Assurance Advisory Committee provides guidance and recommendations related to the standards by which facilities are regulated.
Take a virtual tour around the Radiological Society of North America (RSNA) meeting to see the sights and new technologies displayed across the vast exhibit hall floors.
Such roving imaging vans have been posed as a way to reach more women in rural and underserved communities. But do they unintentionally hurt facility-based efforts?
Between 2004 to 2021, the biggest annual percentage increase in incidence of metastatic breast cancer at diagnosis was among women ages 20-39 (up 2.9%).
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.
